Lemonade (LMND) Stock Looks Strong On Returns But Rich On Sales

Lemonade stock has delivered a very strong 3 year return, yet the current checks still flag it as expensive rather than a clear bargain. Recent news around record revenue and AI driven expansion keeps expectations high, while the broader valuation profile looks more demanding.

• Over the past 3 years, Lemonade has returned about 276.3%, which sets a high bar for future gains to justify the current price.
• The push to widen its insurance footprint and use AI in underwriting and claims can support revenue growth, but ongoing net losses remain a key risk for how the market prices the stock.
• Lemonade scores 0 out of 6 on the broader valuation checks, which suggests the stock leans expensive rather than offering clear value based on these metrics.

For investors, the key question is whether Lemonade's current price leaves enough upside potential to compensate for the risks around profitability and execution.

Find out why Lemonade's -8.2% return over the last year is lagging behind its peers.

Is Lemonade Getting Expensive on Sales?

P/S is a useful lens for Lemonade because the company is still reporting net losses, so sales give a cleaner anchor than earnings. Lemonade currently trades on a P/S ratio of about 4.2x, compared with an insurance industry average of around 1.2x and a peer group average near 1.9x. That is a clear premium to both the wider sector and closer listed peers.

The fair P/S multiple implied by the broader model is about 1.6x, which is also well below where Lemonade trades today. That gap indicates that investors are paying a high price for each dollar of current revenue, even after the recent Q2 2026 news on record sales and AI driven expansion. For you as a shareholder or potential buyer, the question is whether that premium still makes sense given the ongoing net losses and execution risks.

On the P/S multiple, Lemonade stock appears overvalued relative to both sector norms and the model’s fair value range.

See what the numbers say about this price — find out in our valuation breakdown.

The Lemonade Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Lemonade pick up from this valuation puzzle and set out the specific future paths for growth, margins and earnings that would need to play out for Lemonade's stock to trade meaningfully higher or lower than today. Instead of providing a single output from a ratio or model, they show the underlying story that the result relies on so you can see what would need to happen and monitor whether that story is still on track over time.

The community is split on Lemonade, with one side focused on AI driven upside and the other on how fragile that progress might be.

Bull case: 15% undervalued

"Leveraging proprietary AI and tech-enabled expansion across diverse insurance lines and regions positions Lemonade for sustained revenue growth, efficiency gains, and competitive advantage…"

Read the full Bull Case to see why Lemonade could be undervalued

Bear case: 8% overvalued

"It is also what makes the position fragile: Lemonade has increased its exposure to a loss ratio that has only ever been tested in benign conditions…"

Read the full Bear Case to see why Lemonade could be overvalued

Do you think there's more to the story for Lemonade? Head over to our Community to see what others are saying!

The Bottom Line

Lemonade looks overvalued on the current P/S based checks, with the stock carrying a clear premium to both the insurance sector and closer peers even as it continues to report net losses. For you as an investor, the key issue is whether that premium is still justified by the AI driven growth story and expansion plans, or whether expectations have run ahead of what the business can deliver. The crux of the bull versus bear debate is whether Lemonade can translate its revenue momentum into a credible path to sustainable profitability before the market loses patience with the high multiple.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com